BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.

Highlights Beijing Tiantan Biological Products Co., Ltd.

Equities

600161

CNE000000WF9

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
30.22 ^CNY	-0.59%		+5.04%	-2.33%

05-02	ICBC, CCB Name Deputy Party Secretaries	MT
04-12	Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7%	04-12	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-11	CI
Tiantan Biological Products Scraps Clinical Trial of Intravenous Cytomegalovirus Human Immunoglobulin	02-01	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01-10	CI
Didi Global Reports Q3 Revenue of RMB 51.4 Billion, Up 25% YoY	11-13	RE
DIDI- ON NOV 11, YI ZHANG RESIGNED AS DIRECTOR OF THE CO, CHEN S…	11-13	RE
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Tiantan Biological Products' Profit Jumps 47.7% in First Three Quarters; Shares Up 5%	13/10/23	MT
Tiantan Biological Products' Unit Gets Nod to Register Intravenous Human Immunoglobulin, Passes Regulatory Inspection	27/09/23	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13/07/23	CI
Tiantan Biological Products Gets License for Four Plasma Stations	27/06/23	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/04/23	CI
Tiantan Biological Products' Blood Station Gets Plasma Collection Permit	23/02/23	MT
Tiantan Biological Products Gets Permit for Plasma Station	09/02/23	MT
Tiantan Biological Posts 14.8% Rise in Profit in 2022	26/01/23	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/01/23	CI
Tiantan Biological Products Wins Blood Plasma Collection License	05/01/23	MT
Beijing Tiantan Biological Products Unit Obtains Business Permit For Blood Station	19/12/22	MT
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22	CI
Beijing Tiantan Biological Products’ January-September Profit Rises 8% as Revenue Grows 3%	21/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beijing Tiantan Biological Products Co., Ltd.

Equities

600161

CNE000000WF9

Highlights

Filters